Unable to display view head.php file not found.<div class='no_figure_content'>
<div class='transcript'>
  
  <div class='right'>
    <a href="printable.php?figure=complete_references" class="print_link buttonify twoline_print_link" target_orig="_blank" style=''>Print This Page</a>
  </div>
  <h2>Complete References</h2>
    <div class='references complete_references'>
    <!-- Start Goldberg -->
  <h3 class='reference_section'>Goldberg</h3>
    <p>
      <span class='ref_num'>[1](<a href="figure.php?speaker=goldberg&figure=3">Goldberg - figure 3</a>)</span> US MedPed program. www.medped.org.medped.org
    </p>
    <p>
      <span class='ref_num'>[2](<a href="figure.php?speaker=goldberg&figure=3">Goldberg - figure 3</a>)</span> Simon Broome Register Group. Risk of fatal coronary heart disease in familial 
      hypercholesterolaemia. BMJ 1991;303:893-896.
    </p>
    <p>
      <span class='ref_num'>[3](<a href="figure.php?speaker=goldberg&figure=3">Goldberg - figure 3</a>)</span> Versmissen J, Oosterveer DM, Yazdanpanah M, et al. Efficacy of statins in familial 
      hypercholesterolaemia: A long-term cohort study. BMJ 2008; 337: a2423.
    </p>
    <p>
      <span class='ref_num'>[4](<a href="figure.php?speaker=goldberg&figure=3">Goldberg - figure 3</a>)</span> Newson, A. J., Humphries, S. E. Cascade testing in familial hypercholesterolaemia: how 
      should family members be contacted? Europ. J. Hum. Genet. 13: 401-408, 2005.
    </p>
    <!-- End Goldberg -->
    
  <h3 class='reference_section'>Robinson</h3>
    <!-- Start Robinson -->
    <p>
      <span class='ref_num'>[5](<a href="figure.php?speaker=robinson&figure=2">Robinson - figure 2</a>)</span> Versmissen J, Oosterveer DM, Yazdanpanah M, et al. Efficacy of statins in familial 
      hypercholesterolaemia: A long-term cohort study. BMJ 2008; 337: a2423.
    </p>
    <p>
      <span class='ref_num'>[6](<a href="figure.php?speaker=robinson&figure=4">Robinson - figure 4</a>)</span> The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol
lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin
Survival Study (4S). Lancet 1994; 344: 1383-1389.
    </p>
    <p>
      <span class='ref_num'>[7](<a href="figure.php?speaker=robinson&figure=4">Robinson - figure 4</a>)</span> Shepherd J, Cobbe SM, Ford I, et al, for the West of Scotland Coronary Prevention
Study Group. Prevention of coronary heart disease with pravastatin in men with
Hypercholesterolemia. NEJM 1995; 333: 1301 – 1307.
    </p>
    <p>
      <span class='ref_num'>[8](<a href="figure.php?speaker=robinson&figure=4">Robinson - figure 4</a>)</span> Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of
cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised
placebo controlled trial. Lancet 2002; 360: 7–22
    </p>
    <p>
      <span class='ref_num'>[9](<a href="figure.php?speaker=robinson&figure=4">Robinson - figure 4</a>)</span> LaRosa JC, Grundy SM, Waters DD, et al. Intensive Lipid Lowering with Atorvastatin in
Patients with Stable Coronary Disease. N ENgl J Med 2005; 352:
    </p>
    <p>
      <span class='ref_num'>[10](<a href="figure.php?speaker=robinson&figure=4">Robinson - figure 4</a>)</span> Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus Moderate Lipid Lowering
with Statins after Acute Coronary Syndromes. N Engl J Med 2004; 350:1495-504.
    </p>
    <p>
      <span class='ref_num'>[11](<a href="figure.php?speaker=robinson&figure=5">Robinson - figure 5</a>)</span> Kastelein JJP, Akdim F, Stroes ESG, et al. Simvastatin with or without Ezetimibe in
Familial Hypercholesterolemia. N Engl J Med 2008; 358:1431-1443.
    </p>
    <p>
      <span class='ref_num'>[12](<a href="figure.php?speaker=robinson&figure=5">Robinson - figure 5</a>)</span> Sivapalaratnam S, van Loendersloot LL, Hutten BA, et al. Long-term LDL-c lowering in
heterozygous familial hypercholesterolemia normalizes carotid intima-media thickness.
Atherosclerosis 2010;212:571-574.
    </p>
    <p>
      <span class='ref_num'>[13](<a href="figure.php?speaker=robinson&figure=10">Robinson - figure 10</a>)</span> The Coronary Drug Project Research Group. Clofibrate and niacin in coronary heart
disease. JAMA 1975;231:360-81.
    </p>
    <p>
      <span class='ref_num'>[14](<a href="figure.php?speaker=robinson&figure=10">Robinson - figure 10</a>)</span> Buchwald H, Varco R, et al. Effect of partial ileal bypass surgery on mortality and
morbidity from coronary heart disease in patients with hypercholesterolemia. Report of
the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med
1990; 323: 946-955.
    </p>
    <p>
      <span class='ref_num'>[15](<a href="figure.php?speaker=robinson&figure=11">Robinson - figure 11</a>)</span> Rosseb AB, Pedersen TR, Boman K, et al. Intensive lipid lowering with simvastatin and
ezetimibe in aortic stenosis. N Engl J Med. 2008;359.
    </p>
    <p>
      <span class='ref_num'>[16](<a href="figure.php?speaker=robinson&figure=11">Robinson - figure 11</a>)</span> Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with
simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and
Renal Protection): a randomized placebo-controlled trial. The Lancet 2011; Published
Online June 9, 2011 DOI:10.1016/S0140-6736(11)60739-3
    </p>
    <p>
      <span class='ref_num'>[17](<a href="figure.php?speaker=robinson&figure=11">Robinson - figure 11</a>)</span> The ACCORD investigators. Effects of combination lipid therapy in type 2 diabetes
mellitus. N Engl J Med 2010; DOI: 10.1056/NEJMoa1001282. Available at: 
    <!-- <a href="http://www.nejm.org/" target="_blank">http://www.nejm.org/</a>. -->
    http://www.nejm.org/
    </p>

  <h3 class='reference_section'>Gidding</h3>
    <p>
      <span class='ref_num'>[18](<a href="figure.php?speaker=gidding&figure=8">Gidding - figure 8</a>)</span> Cornhill JF, Herderick EE, Vince DG. The clinical morphology of human atherosclerotic
lesions. Lessons form the PDAY studay. Pathobiological Determinants of Atherosclerosis
in Youth. Wien Klin Wochenschr 1995;107(18): 540-543.
    </p>
    <p>
      <span class='ref_num'>[19](<a href="figure.php?speaker=gidding&figure=13">Gidding - figure 13</a>) </span> Wiegman A, Hutten BA, de Groot E, et al. Efficacy and Safety of Statin Therapy in
Children With Familial Hypercholesterolemia. JAMA 2004; 292(3); 331-337.
    </p>

  <h3 class='reference_section'>Toth</h3>
    <p>
      <span class='ref_num'>[20](<a href="figure.php?speaker=toth&figure=6">Toth - figure 6</a>)</span> Hopkins PN, Stephenson S, Wu LL, et al. Evaluation of coronary risk factors in patients
with heterozygous familial hypercholesterolaemia. Am J Cardiol 2001;87:547–53.
    </p>
    <p>
      <span class='ref_num'>[21](<a href="figure.php?speaker=toth&figure=15">Toth - figure 15</a>)</span> US MedPed program. 
      <!-- <a href="http://www.medped.org/" target="_blank">www.medped.org</a> -->
      www.medped.org
    </p>
    <p>
      <span class='ref_num'>[22](<a href="figure.php?speaker=toth&figure=15">Toth - figure 15</a>)</span> Versmissen J, Oosterveer DM, Yazdanpanah M, et al. Efficacy of statins in familial
hypercholesterolaemia: A long-term cohort study. BMJ 2008; 337: a2423.
    </p>
    <p>
      <span class='ref_num'>[23](<a href="figure.php?speaker=toth&figure=15">Toth - figure 15</a>)</span> Simon Broome Register Group. Risk of fatal coronary heart disease in familial
hypercholesterolaemia. BMJ 1991;303:893-896.
    </p>

  <h3 class='reference_section'>Ito</h3>
  <p>
    <span class='ref_num'>[24](<a href="figure.php?speaker=ito&figure=2">Ito - figure 2</a>)</span> Harada-Shiba M, Sugisawa T, Makino H, et al. Impact of Statin Treatment on the
Clinical Fate of Heterozygous Familial Hypercholesterolemia. J Atheroscler THromb
2010;17:667-674.
  </p>
  <p>
    <span class='ref_num'>[25](<a href="figure.php?speaker=ito&figure=5">Ito - figure 5</a>)</span> Stein EA, Ballantyne CM, Windler E, et al. Efficacy and Tolerability of Fluvastatin XL
80 mg Alone, Ezetimibe Alone, and the Combination of Fluvastatin XL 80 mg With
Ezetimibe in Patients With a History of Muscle-Related Side Effects With Other Statins.
Am J Cardiol 2007;101:490-496.
  </p>
  <p>
    <span class='ref_num'>[26](<a href="figure.php?speaker=ito&figure=6">Ito - figure 6</a>)</span> Backes JM, Moriarty PM, RUisinger JF, Gibson CA. Effects of Once Weekly
Rosuvastatin Among Patients With a Prior Statin Intolerance. Am J Cardiol
2007;100:554–555
  </p>
  <p>
    <span class='ref_num'>[27](<a href="figure.php?speaker=ito&figure=13">Ito - figure 13</a>)</span> Buchwald H, Varco RL, Matts JP, et al. Effect of partial ileal bypass surgery on mortality
and morbidity from coronary heart disease in patients with hypercholesterolemia. Report
of the Program on the Surgical Control of the Hyperlipidemias (POSCH). 
N Engl J Med.
<!-- <a href="http://www.ncbi.nlm.nih.gov/pubmed/2205799" target="_blank">N Engl J Med.</a> -->
1990 Oct 4;323(14):946-55.
  </p>
</div><!-- end references -->
</div><!-- end transcript -->
</div>
Unable to display view foot.php file not found.